P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844324.04051.5b |
| _version_ | 1827332543495536640 |
|---|---|
| author | F. Locatelli G. Zugmaier C. Rizzari J. Morris B. Gruhn T. Klingebiel R. Parasole C. Linderkamp C. Flotho A. Petit C. Micalizzi Y. Zeng R. Desai W. Kormany C. Eckert A. Möricke M. Sartor O. Hrusak C. Peters V. Saha L. Vinti A. von Stackelberg |
| author_facet | F. Locatelli G. Zugmaier C. Rizzari J. Morris B. Gruhn T. Klingebiel R. Parasole C. Linderkamp C. Flotho A. Petit C. Micalizzi Y. Zeng R. Desai W. Kormany C. Eckert A. Möricke M. Sartor O. Hrusak C. Peters V. Saha L. Vinti A. von Stackelberg |
| author_sort | F. Locatelli |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:33Z |
| format | Article |
| id | doaj.art-02611177c08447f483e8d60eff6dfd83 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:33Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-02611177c08447f483e8d60eff6dfd832024-03-03T03:19:22ZengWileyHemaSphere2572-92412022-06-01625926010.1097/01.HS9.0000844324.04051.5b202206003-00259P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)F. Locatelli0G. Zugmaier1C. Rizzari2J. Morris3B. Gruhn4T. Klingebiel5R. Parasole6C. Linderkamp7C. Flotho8A. Petit9C. Micalizzi10Y. Zeng11R. Desai12W. Kormany13C. Eckert14A. Möricke15M. Sartor16O. Hrusak17C. Peters18V. Saha19L. Vinti20A. von Stackelberg211 IRCCS Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome, Rome, Italy2 Amgen Research (Munich), Munich, Germany3 MBBM Foundation, ASST Monza, University of Milano-Bicocca, Monza, Italy4 Amgen Inc., Thousand Oaks, United States of America5 Universitaetsklinikum Jena, Jena6 Universitätsklinikum Frankfurt am Main, Frankfurt, Germany7 Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Napoli, Italy8 Medizinische Hochschule Hannover, Hanover9 Universitätsklinikum Freiburg, Freiburg, Germany10 Hopital Armand Trousseau, APHP.Sorbonne Université, Paris, France11 Istituto Pediatrico di Ricerca e Cura a Carattere Scientifico G Gaslini, Genova, Italy4 Amgen Inc., Thousand Oaks, United States of America12 IQVIA Inc., Durham, United States of America4 Amgen Inc., Thousand Oaks, United States of America13 Charité Campus Virchow-Klinikum Pädiatrie m.S. Onkologie/Hämatologie, Berlin14 Univ.-Klinikum Schleswig-Holstein, Kiel, Germany15 Westmead Hospital, Sydney, Australia16 Charles University, Motol University Hospital, Prague, Czechia17 St Anna Children’s Hospital, Vienna, Austria18 Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom1 IRCCS Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome, Rome, Italy20 Charite Universitaetsmedizin CVK Berlin, Berlin, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000844324.04051.5b |
| spellingShingle | F. Locatelli G. Zugmaier C. Rizzari J. Morris B. Gruhn T. Klingebiel R. Parasole C. Linderkamp C. Flotho A. Petit C. Micalizzi Y. Zeng R. Desai W. Kormany C. Eckert A. Möricke M. Sartor O. Hrusak C. Peters V. Saha L. Vinti A. von Stackelberg P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) HemaSphere |
| title | P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) |
| title_full | P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) |
| title_fullStr | P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) |
| title_full_unstemmed | P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) |
| title_short | P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) |
| title_sort | p359 improved overall survival and mrd clearance with blinatumomab vs chemotherapy as pre transplant consolidation in pediatric high risk first relapse b cell precursor acute lymphoblastic leukemia b all |
| url | http://journals.lww.com/10.1097/01.HS9.0000844324.04051.5b |
| work_keys_str_mv | AT flocatelli p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT gzugmaier p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT crizzari p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT jmorris p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT bgruhn p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT tklingebiel p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT rparasole p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT clinderkamp p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT cflotho p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT apetit p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT cmicalizzi p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT yzeng p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT rdesai p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT wkormany p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT ceckert p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT amoricke p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT msartor p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT ohrusak p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT cpeters p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT vsaha p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT lvinti p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball AT avonstackelberg p359improvedoverallsurvivalandmrdclearancewithblinatumomabvschemotherapyaspretransplantconsolidationinpediatrichighriskfirstrelapsebcellprecursoracutelymphoblasticleukemiaball |